The immunopathogenesis of SARS-CoV-2 infection in children: diagnostics, treatment and prevention

Harsita Patel1, Andrew McArdle1, Eleanor Seaby1,2,3

  • 1Department of Infectious Disease, Section of Paediatric Infectious Disease Imperial College London London UK.

Insights

Children exhibit distinct COVID-19 (coronavirus disease) responses compared to adults, with lower mortality. Understanding pediatric immune protection may reveal insights into adult disease severity and new therapies.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pediatrics

Background:

  • Paediatric COVID-19 (coronavirus disease) presents with significantly lower morbidity and mortality than adult cases.
  • Age-related differences in innate and adaptive immune responses likely explain variations in disease severity.
  • Severe outcomes in adults are driven by immunopathogenesis, offering potential insights from pediatric immunity.

Purpose of the Study:

  • To review and compare immune responses to SARS-CoV-2 in children versus adults.
  • To investigate pediatric immune features that may protect against severe COVID-19.
  • To explore therapeutic strategies informed by pediatric immune responses.

Main Methods:

  • Review of studies on pre-existing immunity, cytokine profiles, and immune cell responses (innate, B-cell, T-cell, antibody, vaccine) in children with acute COVID-19 and multisystem inflammation.
  • Comparison of pediatric responses with those in COVID-19 adults and healthy controls.
  • Analysis of clinical presentations including multisystem inflammatory syndrome in children (MIS-C).

Main Results:

  • Children generally display milder acute COVID-19 symptoms but can develop delayed multisystem inflammation (MIS-C).
  • Immune responses, including antibody and T-cell profiles, differ between pediatric and adult COVID-19.
  • Kawasaki Disease-like presentations and cardiac involvement (coronary artery aneurysms) are noted in some pediatric cases.

Conclusions:

  • Understanding pediatric immune responses to SARS-CoV-2 is critical for deciphering adult COVID-19 severity.
  • Pediatric immune system characteristics may hold keys to novel therapeutic targets.
  • Further research is needed to address knowledge gaps in pediatric COVID-19 immunology and treatment.